Related Experiment Video

Updated: Aug 17, 2026

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells
08:00

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells

Published on: January 12, 2015

Human embryonic stem cells: genetic manipulation on the way to cardiac cell therapies

Jennifer C Moore1, Linda W van Laake, Stefan R Braam

  • 1Hubrecht Laboratory, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.

Reproductive Toxicology (Elmsford, N.Y.)
|June 22, 2005
PubMed

Insights

Researchers developed a new method to genetically modify human embryonic stem cells (hESC), enabling the creation of traceable cells for transplantation therapies. This advance is crucial for advancing stem cell research and regenerative medicine.

Area of Science:

  • Stem Cell Biology
  • Regenerative Medicine
  • Cardiovascular Research

Background:

  • Human embryonic stem cells (hESC) hold therapeutic potential, particularly for cardiac repair.
  • Progress in hESC-based therapies is hindered by challenges in genetic modification and tracking cells in vivo.
  • Existing methods for genetic manipulation of hESC are limited.

Purpose of the Study:

  • To review the current state of hESC-derived cardiomyocyte transplantation in animal models.
  • To address the challenge of generating genetically marked hESC for improved in vivo analysis.
  • To describe the successful generation and characterization of a novel, genetically modified hESC line.

Main Methods:

  • Review of existing literature on hESC transplantation and genetic modification techniques.
  • Development and application of novel transfection methodologies for hESC.
  • Characterization of a new hESC line expressing Green Fluorescent Protein (GFP).

Main Results:

  • Identified limitations in current genetic marking strategies for hESC.
  • Successfully generated a new hESC line that constitutively expresses GFP.
  • Demonstrated that the modified hESC line can differentiate into cardiomyocytes with ventricular-like electrophysiological properties.

Conclusions:

  • Genetically marking hESC is essential for advancing transplantation therapies and in vivo studies.
  • The newly developed genetically modified hESC line provides a valuable tool for tracking and functional analysis.
  • This work paves the way for improved preclinical testing of hESC-based cardiac therapies.

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Related Concept Videos

Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.